Literature DB >> 33297803

Phosgene oxime: a highly toxic urticant and emerging chemical threat.

Satyendra K Singh1, Joshua A Klein1, Holly N Wright1, Neera Tewari-Singh1.   

Abstract

Highly toxic industrial chemicals that are widely accessible, and hazardous chemicals like phosgene oxime (CX) that can be easily synthesized, pose a serious threat as potential chemical weapons. In addition, their accidental release can lead to chemical emergencies and mass casualties. CX, an urticant, or nettle agent, grouped with vesicating agents, causes instant pain, injury and systemic effects, which can lead to mortality. With faster cutaneous penetration, corrosive properties, and more potent toxicity compared to other vesicating agents, CX causes instantaneous and severe tissue damage. CX, a potential chemical terrorism threat agent, could therefore be weaponized with other chemical warfare agents to enhance their harmful effects. CX is the least studied vesicant and its acute and long-term toxic effects as well as its mechanism of action are largely unknown. This has hampered the identification of therapeutic targets and the development of effective medical countermeasures. There are only protective measures, decontamination, and supportive treatments available for reducing the toxic effects from CX exposure. This review summarizes CX toxicity, its known mechanism of action, and our current studies exploring the role of mast cell activation and associated signaling pathways in CX cutaneous exposure under the National Institutes of Health Countermeasures Against Chemical Threats program. Potential treatment options and the development of effective targeted countermeasures against CX-induced morbidity and mortality is also discussed.

Entities:  

Keywords:  Phosgene oxime; inflammation; mast cells; medical countermeasures; molecular mechanisms; toxicity; urticant; vesicating agent

Mesh:

Substances:

Year:  2020        PMID: 33297803      PMCID: PMC8087642          DOI: 10.1080/15376516.2020.1861670

Source DB:  PubMed          Journal:  Toxicol Mech Methods        ISSN: 1537-6516            Impact factor:   2.987


  35 in total

1.  Cutaneous exposure to vesicant phosgene oxime: Acute effects on the skin and systemic toxicity.

Authors:  Neera Tewari-Singh; Dinesh G Goswami; Rama Kant; Claire R Croutch; Robert P Casillas; David J Orlicky; Rajesh Agarwal
Journal:  Toxicol Appl Pharmacol       Date:  2017-01-11       Impact factor: 4.219

2.  Sulfur mustard analog, 2-chloroethyl ethyl sulfide-induced skin injury involves DNA damage and induction of inflammatory mediators, in part via oxidative stress, in SKH-1 hairless mouse skin.

Authors:  Anil K Jain; Neera Tewari-Singh; Mallikarjuna Gu; Swetha Inturi; Carl W White; Rajesh Agarwal
Journal:  Toxicol Lett       Date:  2011-06-21       Impact factor: 4.372

3.  Myeloperoxidase deficiency attenuates nitrogen mustard-induced skin injuries.

Authors:  Anil K Jain; Neera Tewari-Singh; Swetha Inturi; David J Orlicky; Carl W White; Rajesh Agarwal
Journal:  Toxicology       Date:  2014-03-12       Impact factor: 4.221

4.  Topical nitrogen mustard exposure causes systemic toxic effects in mice.

Authors:  Dinesh G Goswami; Dileep Kumar; Neera Tewari-Singh; David J Orlicky; Anil K Jain; Rama Kant; Raymond C Rancourt; Deepanshi Dhar; Swetha Inturi; Chapla Agarwal; Carl W White; Rajesh Agarwal
Journal:  Exp Toxicol Pathol       Date:  2014-12-04

Review 5.  Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure.

Authors:  Michael P Shakarjian; Diane E Heck; Joshua P Gray; Patrick J Sinko; Marion K Gordon; Robert P Casillas; Ned D Heindel; Donald R Gerecke; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2009-10-15       Impact factor: 4.849

Review 6.  Mustard gas: imminent danger or eminent threat?

Authors:  Matthew J Geraci
Journal:  Ann Pharmacother       Date:  2008-01-22       Impact factor: 3.154

Review 7.  Pathophysiology of urticaria.

Authors:  Ana Hennino; Fréderic Bérard; Isabelle Guillot; Nathalie Saad; Auore Rozières; Jean-François Nicolas
Journal:  Clin Rev Allergy Immunol       Date:  2006-02       Impact factor: 8.667

Review 8.  The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.

Authors:  Tse Wen Chang; Christina Chen; Chien-Jen Lin; Martin Metz; Martin K Church; Marcus Maurer
Journal:  J Allergy Clin Immunol       Date:  2014-06-17       Impact factor: 10.793

9.  Clinical progression of ocular injury following arsenical vesicant lewisite exposure.

Authors:  Neera Tewari-Singh; Claire R Croutch; Richard Tuttle; Dinesh G Goswami; Rama Kant; Eric Peters; Tara Culley; David A Ammar; Robert W Enzenauer; J Mark Petrash; Robert P Casillas; Rajesh Agarwal
Journal:  Cutan Ocul Toxicol       Date:  2016-03-22       Impact factor: 1.820

10.  Sulfur mustard toxicity following dermal exposure: role of oxidative stress, and antioxidant therapy.

Authors:  Victor Paromov; Zacharias Suntres; Milton Smith; William L Stone
Journal:  J Burns Wounds       Date:  2007-10-30
View more
  1 in total

1.  Supporting discovery and development of medical countermeasures for chemical injury to eye and skin.

Authors:  Houmam Araj; Hung Tseng; David T Yeung
Journal:  Exp Eye Res       Date:  2022-06-15       Impact factor: 3.770

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.